# Contact Meds PT-141: Editorial Questions on the PT-141 Digest

> Contact Meds PT-141 with editorial questions or corrections about the PT-141 (bremelanotide) research digest. Editorial only; no medical advice and no product sales.

For corrections, sourcing questions, and editorial feedback on the bremelanotide record. Not for medical advice.

## What to use this form for

This is an editorial contact channel for the PT-141 (bremelanotide) research digest. Use it for corrections to a citation, questions about how a figure was sourced, or feedback on the summaries. We read every message about the accuracy of the record.

What we cannot do: provide medical advice, recommend a dose, answer questions about personal health, or sell, supply, or source any product. Meds PT-141 is an independent editorial publisher, not a clinic and not a vendor — for any question about your own health or about taking a medication, consult a qualified healthcare professional. The approved product is a prescription medicine, and decisions about it belong with a clinician.

## Reaching the editors

Send a message through the form below. Please include the page and, if you are flagging a sourcing issue, the citation number and the specific claim, so we can check it against the source quickly. Corrections that hold up against the published record are made promptly — accuracy of the cited material is the whole point of this digest, and well-sourced corrections genuinely help.

---

A chrome-bright console reading of the bremelanotide record — the one approved indication, the modest effect, and the honest tolerability profile logged to source, with the community field reports quarantined apart; not a clinic, not a vendor, not a prescription.